NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 41 filers reported holding NEURODERM LTD in Q3 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $39,000 | +85.7% | 996 | +42.3% | 0.00% | – |
| Q2 2017 | $21,000 | +10.5% | 700 | 0.0% | 0.00% | – |
| Q1 2017 | $19,000 | +18.8% | 700 | 0.0% | 0.00% | – |
| Q4 2016 | $16,000 | +23.1% | 700 | 0.0% | 0.00% | – |
| Q3 2016 | $13,000 | +18.2% | 700 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | +10.0% | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $10,000 | -93.3% | 700 | -92.0% | 0.00% | – |
| Q4 2015 | $149,000 | +964.3% | 8,736 | +1148.0% | 0.00% | – |
| Q3 2015 | $14,000 | -33.3% | 700 | -48.8% | 0.00% | – |
| Q2 2015 | $21,000 | – | 1,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |